MMH
KITE

Menora Mivtachim Holdings’s Kite Pharma, Inc. KITE Stock Holding History

Menora Mivtachim Holdings’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-248,104
Closed -$44.6M – 89
2017
Q3 		$44.6M Sell
248,104
-975,795
-80% -$136M 1.81% 20
2017
Q2 		$127M Sell
1,223,899
-210,000
-15% -$17.1M 5.91% 2
2017
Q1 		$113M Buy
1,433,899
+175,000
+14% +$10.8M 5.71% 2
2016
Q4 		$56.4M Buy
1,258,899
+250,000
+25% +$12.3M 2.9% 11
2016
Q3 		$56.4M Buy
1,008,899
+324,000
+47% +$18.1M 3.1% 13
2016
Q2 		$34.2M Buy
684,899
+189,911
+38% +$9.33M 1.93% 20
2016
Q1 		$22.7M Buy
494,988
+95,000
+24% +$4.6M 1.36% 28
2015
Q4 		$24.6M Sell
399,988
-10,014
-2% -$705K 1.57% 27
2015
Q3 		$22.8M Sell
410,002
-88,058
-18% -$5.54M 1.7% 25
2015
Q2 		$30.4M Buy
498,060
+229,530
+85% +$13.1M 2.31% 17
2015
Q1 		$15.5M Buy
+268,530
New +$18M 1.25% 28

Menora Mivtachim Holdings's KITE Position: Q4 2017 in Review

Menora Mivtachim Holdings sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 248,104 shares — an estimated $44.6M sold.

Menora Mivtachim Holdings first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $127M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Menora Mivtachim Holdings reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Menora Mivtachim Holdings sold 248,104 Kite Pharma, Inc. shares in Q4 2017, an estimated $44.6M.
  • Menora Mivtachim Holdings first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
  • Menora Mivtachim Holdings's Kite Pharma, Inc. position peaked at $127M in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Menora Mivtachim Holdings's 13F filing for Q4 2017, filed 13 Feb 2018.